Literature DB >> 16085356

The roles of Chk 1 and Chk 2 in hypoxia and reoxygenation.

Ester M Hammond1, Rachel A Freiberg, Amato J Giaccia.   

Abstract

Both Chk 1 and Chk 2 are critically important checkpoint kinases. Chk 1 is an essential gene that is required for normal cell division and Chk 2 has been found to be mutated in an ever-growing list of human malignancies. Our recent studies indicate that both Chk 1 and Chk 2 have roles to play in the physiological stress of hypoxia/reoxygenation. Loss or inhibition of either kinase sensitizes cells to hypoxia/reoxygenation indicating that either or both could represent significant therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16085356     DOI: 10.1016/j.canlet.2005.06.029

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

1.  Exposure to acute hypoxia induces a transient DNA damage response which includes Chk1 and TLK1.

Authors:  Isabel M Pires; Zuzana Bencokova; Chris McGurk; Ester M Hammond
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

2.  Hypoxia activates tumor suppressor p53 by inducing ATR-Chk1 kinase cascade-mediated phosphorylation and consequent 14-3-3γ inactivation of MDMX protein.

Authors:  Jun-Ho Lee; Yetao Jin; Guifen He; Shelya X Zeng; Yunyuan V Wang; Geoffrey M Wahl; Hua Lu
Journal:  J Biol Chem       Date:  2012-05-03       Impact factor: 5.157

Review 3.  Multifaceted control of DNA repair pathways by the hypoxic tumor microenvironment.

Authors:  Susan E Scanlon; Peter M Glazer
Journal:  DNA Repair (Amst)       Date:  2015-05-01

4.  WEE1 inhibition enhances sensitivity to hypoxia/reoxygenation in HeLa cells.

Authors:  Tatsuaki Goto; Hisao Homma; Atsushi Kaida; Masahiko Miura
Journal:  J Radiat Res       Date:  2019-10-23       Impact factor: 2.724

5.  Differential Effects of IGF-1R Small Molecule Tyrosine Kinase Inhibitors BMS-754807 and OSI-906 on Human Cancer Cell Lines.

Authors:  María Fuentes-Baile; María P Ventero; José A Encinar; Pilar García-Morales; María Poveda-Deltell; Elizabeth Pérez-Valenciano; Víctor M Barberá; Javier Gallego-Plazas; Álvaro Rodríguez-Lescure; José Martín-Nieto; Miguel Saceda
Journal:  Cancers (Basel)       Date:  2020-12-11       Impact factor: 6.639

Review 6.  Targeting hypoxic cells through the DNA damage response.

Authors:  Monica Olcina; Philip S Lecane; Ester M Hammond
Journal:  Clin Cancer Res       Date:  2010-09-27       Impact factor: 12.531

7.  In Vitro Antiproliferative Effect of Arthrocnemum indicum Extracts on Caco-2 Cancer Cells through Cell Cycle Control and Related Phenol LC-TOF-MS Identification.

Authors:  Mondher Boulaaba; Khaoula Mkadmini; Soninkhishig Tsolmon; Junkyu Han; Abderrazak Smaoui; Kiyokazu Kawada; Riadh Ksouri; Hiroko Isoda; Chedly Abdelly
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-30       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.